Search images on Google Product Monograph
Active Ingredients:
- insulin glulisine (recombinant dna origin), 100 UNIT/ML
DIN: 02279460
Dosage Form(s): SOLUTION
Route(s) of Administration: SUBCUTANEOUS
Description: 10ML VIAL
Schedule: Schedule D
Company: SANOFI-AVENTIS CANADA INC – official site
ATC:
- A10 - DRUGS USED IN DIABETES (ATC, WHO, Wiki)
- A10A - INSULINS AND ANALOGUES (ATC, WHO)
- A10AB - Insulins and analogues for injection, fast-acting (ATC, WHO)
- A10AB06 - INSULIN GLULISINE (WHO)
Reference brand drug: Apidra
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 10ML
External Links for Apidra:
Search on Google
Sanofi-Aventis Canada Inc
Go to Sanofi-Aventis website to see drug product details. Sometimes you can find apidra photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.